FDA Inspection
Reproductive Technologies, Inc.Reproductive Technologies, Inc. – FDA Inspection, Nov 18, 2024
Record Details
This FDA Inspection record concerns Reproductive Technologies, Inc., with an inspection on November 18, 2024, issued by the San Francisco District Office, covering biologics.
- Person
View Company Profile
ID · dc81b15b-899c-4381-9a5f-624d46bbe7c2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1254426
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.50(a)Determination based on screening and testing
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Reproductive Technologies, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 13, 2021 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 16, 2019 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 8, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 20, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 17, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Reproductive Technologies, Inc.
- FDA Inspection 1153089 - 2021-09-13
- FDA Inspection 1100185 - 2019-08-16
- FDA Inspection 983894 - 2016-09-08
- FDA Inspection 861157 - 2013-12-20
- FDA Inspection 768779 - 2012-02-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.